Lymphoma in dogs is rarely curable in the traditional sense, but it is highly treatable. With the most common chemotherapy protocols, roughly 85 to 95 percent of dogs achieve complete remission, meaning their cancer becomes undetectable. The distinction that matters: remission is not the same as a cure. Most dogs eventually relapse, and median survival times with treatment range from about 6 to 13 months depending on the type of lymphoma. Without any treatment, dogs typically survive only 4 to 6 weeks after diagnosis.
What Remission Actually Means
When veterinary oncologists talk about treating canine lymphoma, they use the word “remission” rather than “cure.” Complete remission means the cancer can no longer be detected on physical exam or imaging. Dogs in remission typically look and act completely normal. Their swollen lymph nodes shrink back to normal size, their appetite returns, and their energy bounces back.
The problem is that microscopic cancer cells almost always persist somewhere in the body. Over time, those cells multiply and the lymphoma returns. A first remission might last several months, and a second remission (achieved with a different drug or protocol) is usually shorter than the first. Each successive remission tends to be briefer and harder to achieve.
How B-Cell and T-Cell Types Affect Outlook
One of the most important factors in your dog’s prognosis is the immunophenotype, which is determined through a test on the cancer cells. Dogs with B-cell lymphoma (the more common type) respond better to treatment and live longer. With a standard chemotherapy protocol, B-cell lymphoma carries a median survival time of about 12 months. Dogs with T-cell lymphoma have a median survival of 6 to 9 months.
This difference matters at every stage of treatment. In relapsed cases treated with newer drugs, B-cell dogs responded 67 percent of the time at first relapse, compared to significantly lower rates for T-cell cases. Your veterinarian will likely recommend testing for immunophenotype early on because it shapes both the treatment plan and realistic expectations.
What Treatment Looks Like
The gold standard for canine lymphoma is a multi-drug chemotherapy protocol called CHOP, which uses a rotating combination of four drugs given over several months. A simpler protocol called COP uses three drugs and is sometimes chosen for older dogs or when cost is a concern. In one study of elderly dogs, median survival was 181 days with COP and 202 days with CHOP, though the difference wasn’t statistically significant in that small group.
Most dogs tolerate chemotherapy far better than people expect. Dogs don’t lose their fur (though some breeds with continuously growing coats, like poodles, may thin out), and the majority maintain a good quality of life throughout treatment. That said, side effects do happen. In a study of 155 dogs undergoing cancer chemotherapy, about 80 percent experienced at least one adverse event, though most were mild. Roughly 32 percent had a serious adverse event at some point during treatment, and about 24 percent needed hospitalization. Only about 8 percent had to stop chemotherapy entirely because of side effects.
Treatment typically involves visits to the veterinary oncologist every one to two weeks for several months. Each visit is usually quick. Dogs receive their drugs and go home the same day. The total cost of a full CHOP protocol generally runs between $5,000 and $10,000, depending on the clinic and the dog’s size.
The One Treatment That Can Cure
There is one option that offers a genuine chance at a cure: bone marrow transplant (technically called hematopoietic stem cell transplant). This procedure involves giving a very high dose of radiation to destroy all the cancer cells in the body, then transplanting healthy stem cells to rebuild the dog’s immune system. NC State College of Veterinary Medicine reports a cure rate of at least 30 percent for dogs that receive a bone marrow transplant, compared to just 0 to 2 percent with standard chemotherapy alone.
The catch is significant. Bone marrow transplants are only available at a handful of veterinary centers in the United States, cost $15,000 or more, and carry real risks during the recovery period when the dog has essentially no immune system. Dogs need to be in complete remission before the transplant, and not every dog is a candidate. Still, for owners who can access it, this is currently the closest thing to a cure for canine lymphoma.
How Staging Affects the Picture
Veterinary oncologists stage lymphoma using a five-level system. Stage I means only a single lymph node is affected, while Stage V means the cancer has spread to the blood, bone marrow, or other organs beyond the lymphatic system. Most dogs are diagnosed at Stage III or higher because the disease tends to spread quickly and quietly before anyone notices the swollen lymph nodes.
Each stage is also classified as substage “a” (no systemic symptoms) or substage “b” (symptoms like fever, significant weight loss, or high blood calcium levels). Dogs in substage “b” generally have a worse prognosis than those in substage “a,” even at the same stage number. A dog that still feels great at diagnosis has a better chance of responding well to treatment than one that’s already losing weight and feeling sick.
Prednisolone Alone as a Palliative Option
Some owners choose not to pursue full chemotherapy, whether for financial reasons, the dog’s age, or personal preference. In those cases, a steroid like prednisolone can temporarily shrink lymph nodes and improve how a dog feels. This isn’t a substitute for chemotherapy, and it typically extends survival by only a few weeks beyond the 4 to 6 week untreated baseline. It’s worth knowing, however, that starting prednisolone before consulting an oncologist can reduce the effectiveness of later chemotherapy, so it’s best to have that conversation first.
What a Realistic Timeline Looks Like
For a dog with the most common form (multicentric B-cell lymphoma) treated with a CHOP protocol, here’s a rough picture: remission is usually achieved within the first few weeks of treatment. The protocol runs for about 19 to 25 weeks. After treatment ends, dogs are monitored regularly. The first remission typically lasts several months. When relapse occurs, a second protocol or a different drug can often achieve another remission, though it’s usually shorter.
Some dogs beat the statistics significantly. About 20 to 25 percent of dogs with B-cell lymphoma treated with CHOP are still alive at the two-year mark. A small fraction live three years or more. These long-term survivors are the exception, but they exist, and researchers are still trying to understand what makes their cases different.
The honest answer to the question is that lymphoma in dogs is almost never cured by conventional treatment, but it is one of the most responsive cancers to chemotherapy. Most dogs get months of good-quality life that they wouldn’t have had otherwise, and bone marrow transplant offers a real, if limited, path to a true cure.